Longevity Science Podcast

A longevity scientist draws a clear line: promotional claims aren’t scientific findings—and calling them a blatant lie matters. 🔗 Watch the full video: youtu.be/IrfBCWadCm0 #Longevity #Science

Biological-age tests can sound precise, but their results may be inaccurate and hard to interpret. Without regulation or clinical validation, a number isn’t the same as a reliable measure. 🔗 Watch the full video: youtu.be/IrfBCWadCm0 #HealthScience #Longevity

Curing major diseases may add a few years to life. Slowing aging could reshape the whole curve of human longevity. 🔗 Watch the full video: youtu.be/IrfBCWadCm0#Longevi… #AgingScience

Questionable supplement claims can persist when enforcement against deceptive advertising is limited. Who’s holding the industry accountable? Watch the full video: youtu.be/IrfBCWadCm0 #Supplements #ConsumerHealth

Healthcare shouldn’t wait for disease to take hold. Preventing illness may be easier than reversing it—so research and care need to shift from reacting to acting early. 🔗 Watch the full video: youtu.be/IrfBCWadCm0 #PreventiveHealth #Healthcare

Natural products for health: It's not just about 'natural.' We need to talk bioactivity, proper dosing, and the difference between photo-resiliency and actual sunblock. Understanding these nuances is key. #HealthTips #NaturalRemedies

Breakthrough for canine heart health: Rapamycin treatment shows statistically significant improvement in left ventricular function in dogs. Visualized on scatter plot, this offers new hope for furry friends. Watch the full video: youtu.be/wSCxcoLkxBI #DogHealth #VetMed

Can we slow down aging in our furry friends? The Dog Aging Project is testing new approaches in clinical trials, aiming to boost both lifespan and health span for our beloved companions. #DogHealth #AgingResearch

The TRIAD study design is key. It goes beyond lifespan, exploring randomization and secondary endpoints to unlock deeper insights. Watch the full video: youtu.be/wSCxcoLkxBI #TRIADstudy #ClinicalResearch

The TRIAD study design delves into dosage, duration, and primary endpoints, specifically assessing healthspan metrics. It's a deep dive into understanding longevity. Watch the full video: youtu.be/wSCxcoLkxBI #Healthspan #TRIADstudy

Help advance canine health research! Nominate your dog for the TRIAD clinical trial. Check your dog's eligibility and learn more on the Dog Aging Project website. #DogAgingProject #ClinicalTrial

Can dogs live longer and healthier lives with rapamycin? The TRIAD trial is investigating this question, studying the drug's impact on aging canine health span and lifespan. #DogHealth #Longevity

Current aging studies often focus on the sick, and while biological clocks track health, they don't always reflect true biological aging. The nuance matters. #AgingResearch #HealthScience

Concerns are rising about statins potentially linking to neurodegenerative diseases by impacting brain cholesterol. Is it possible to over-modulate cholesterol? #Statins #Health #Neuroscience

Montana's initiative is generating quality data from regulated medical environments, building scientific confidence for potential FDA approval. It addresses broad medical needs, including therapies for cancer and dementia, not just longevity. #MedicalResearch #FDAApproval

Contrary to popular belief, age-specific dementia rates have been declining for decades. At 70 or 80, you're less likely to be diagnosed with dementia now than at any point in history. #DementiaFacts #HealthTrends

NAD drips can cause serious adverse reactions like chest pressure. It's crucial to approach these treatments with caution and be aware of potential risks. #NAD #HealthRisks

Curiosity about psychedelics has shifted from skepticism to investigating their value in treating neurodegenerative and mental diseases, with potential impacts across the whole body. #PsychedelicResearch #Neuroscience

Microdosing surprisingly improved skin health in aged mice, dramatically reducing dermatitis. This unexpected finding suggests a modest survival benefit and a pronounced positive effect on skin. #Microdosing #HealthResearch

Exciting news! We're launching the first-ever human clinical trial on psilocybin for healthy aging, called 'Long Life'. Funded by the Vail Behavioral Health Foundation, enrollment begins in Vail this November. #Longevity #ClinicalTrials